Enzolytics Inc.

OTC : ENZC

Enzolytics Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics. In addition, the company's proprietary cell line produces human monoclonal antibodies that target and neutralizes the HIV virus. Enzolytics Inc. is based in Plano, Texas.

Information

Website
https://enzolytics.com
Sector
Healthcare
Industry
Biotechnology
Type
Common Stock
Country
United States

Price

USD 0.00

Symbol

ENZC

Type

Common Stock

Previous Close

 :

0.00

52 Week Range

 :

0.00 - 0.04

Volume

 :

13,104,307.00

Average Volume

 :

7,851,268.00

High

 :

0.00

Low

 :

0.00

Change

 :

-0.00

Percent change (%)

 :

-1.67

Stakeville

A Free-to-Play Trading Game. Sharpen your skills, trade stocks, and have fun!

Play Now
Getting Started
Get Your Free Account For Educational Purpose Knowledgebase
Legal
Cookie Policy Privacy Policy Terms & Conditions
Customer Service
Help Desk Support Stakeville Newsletter
Stay Connected
Contact Us Official Blog About Us
Disclaimer: Stakeville is a simulation trading game. All trades and stock prices are fictional and do not reflect real-world markets. This game is for entertainment purposes only and does not involve real financial transactions. Read more...